The NeuroTech Institute in partnership with The Ohio State University and Battelle and led by CEO Dr. Tim Lucas, MD, PhD and COO Heather Sever, engage an innovative, collaborative approach to developing new technologies and treatments for patients with neurological disorders.

Offering medical device, diagnostics and life sciences technology commercialization consulting, product development and manufacturing, fund raising, board of directors, board of advisor.

We have developed an innovative, adjustable length angioplasty balloon for peripheral and coronary disease. The INFINITY DEFENDER(tm) for DCB and INFINITY Precision(tm) for non-drug angioplasty. INFINITY Precision received US FDA clearance in June 2020. The Company is seeking strategic partnerships.

VENTUREMED IS AN INNOVATOR in vessel preparation and drug delivery for the interventional treatment of peripheral artery disease (PAD). The company’s technologies make vessel preparation simpler, quicker and more cost-effective. VentureMed offers interventionalists and their patients around the world state-of-the-art devices for treating long, complicated lesions in PAD. Founded by a vascular surgeon, VentureMed is committed to improving patient and economic outcomes.

IRDx, Inc., is an early stage medical diagnostic company developing and commercializing serum based diagnostic tests utilizing novel Mid-Infrared Microspectroscopy and multivariated ananlysis tools to identify proprietary biomarkers.

Co-founder of Cleveland Clinic spinout. Surgical instrumentation for skin biopsy and sutureles closure, early detection of melanoma and other skin disorders.